Latest News
Lisata Therapeutics, Inc.
- Form ARS LISATA THERAPEUTICS, For: Dec 31
- Form DEF 14A Lisata Therapeutics For: 19 October By Investing.com
- Lisata Therapeutics Expands Board, Appoints Independent Director
- Small cap wrap: Nextech3D.ai, Nine Mile Metals, Lisata Therapeutics, Dune Oil...
- Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
- Lisata appoints Jeffrey Farrow to its Board and Audit Committee
- Lisata Therapeutics adds Jeffrey Farrow to board of directors
- Lisata Therapeutics secures US patent for pancr...
- Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly
- Marea Therapeutics, a Subsidiary of Lisata Therapeutics,
- Lisata's Marea Therapeutics to present Phase 2b data on MAR001 at AHA 2026
- Lisata subsidiary Marea Therapeutics gets late-breaking slot at AHA Scientific Sessions
Headlines from the last 30 days, linking to the original publishers. See all market news →